Despite growing clamor for drug makers and researchers to publish clinical trial results, many studies are not disclosed to the public, according to a new study. To wit, nearly 30 percent of 400 randomly selected trials that were completed in 2008 had not been published in a medical journal or posted on the ClinicalTrials.gov four years later. And smaller trials that occur at the earlier stages of development and were funded exclusively by the pharmaceutical industry – specifically, Phase II – were less likely to be published, according to the study in PLOS One.
Hey, check out all the research scientist jobs. Post your resume today!
